Bottom line
SHPAX vs SHPCX: the short answer
SHPAX and SHPCX are two share classes of the same fund — Health & Biotechnology Portfolio — so they hold the identical portfolio. The differences are cost, minimums and how you buy them.
SHPAX is cheaper at 3% vs 3.6% — a difference of $60 a year per $10,000 invested.
Over five years, SHPCX returned +3.7% a year vs +3.1% for SHPAX.
SHPAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
SHPAX vs SHPCX side by side
| SHPAX | SHPCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Saratoga Advantage | Saratoga Advantage |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 3% | 3.6% |
| Annual cost per $10k | $300 | $360 |
| 10-yr cost on $10k (prospectus) | $3,702 | $3,862 |
| Max front load | 5.75% | 0% |
| 12b-1 fee | — | — |
| 1-yr return | −5.5% | −1.3% |
| 5-yr return (annualized) | +3.1% | +3.7% |
| 10-yr return (annualized) | +4.1% | +4.1% |
| Best quarter | +15.0% | +15.0% |
| Worst quarter | −13.0% | −13.0% |
| Net assets (fund) | $10.5M | $10.5M |
| Number of holdings | 29 | 29 |
| Portfolio turnover | 22% | 22% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHPAX | SHPCX | Difference |
|---|---|---|---|
| 2024 | +0.3% | −0.3% | +0.6% |
| 2023 | −0.4% | −0.9% | +0.6% |
| 2022 | +2.0% | +1.4% | +0.6% |
| 2021 | +16.7% | +16.0% | +0.7% |
| 2020 | +3.6% | +3.0% | +0.6% |
| 2019 | +16.2% | +15.4% | +0.8% |
| 2018 | −5.5% | −6.0% | +0.5% |
| 2017 | +12.0% | +11.3% | +0.7% |
| 2016 | −2.0% | −2.5% | +0.5% |
| 2015 | +6.9% | +6.3% | +0.7% |
Source: Fund prospectus bar charts
FAQ
What is the difference between SHPAX and SHPCX?
Which is cheaper, SHPAX or SHPCX?
Should I own both SHPAX and SHPCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.